Advocacy Initiatives

Remote Ischaemic Conditioning in Lymphoma Patients Receiving Anthracyclines (RESILIENCE)

RESILIENCE is a Horizon 2020 project which started on 1 June 2021 with the goal to test the efficacy of a novel intervention (remote ischemic preconditioning) to reduce AC-induced HF, new MRI sequences as marker of cardiotoxicity and a protocol for patients’ empowering in the development of the research. It will run until 31 May 2026.

Find out more about the project 

EU's Beating Cancer Plan

The Council, in collaboration with the ESC Advocacy Committee, contributes to the EU's Beating Cancer Plan through the following initiatives:

• Collaboration with the European Cancer Patients Coalition.
  • Development of a White paper entitled: The impact of cancer-related comorbidities on patient treatment, treatment efficacy, survivorship, and quality of life -> pending publication.
  • Joint statement prepared calling for greater focus on cancer comorbidities.
  • Further joint initiatives are planned during the European Week Against Cancer
• Collaboration with the European Cancer Organisation (ECO)
  • Joint letter sent to J Ryan, European Commission Health & Consumers Directorate-General, underlining cardio-oncology issues and current needs.

Other Advocacy Initiatives

The Council is working to build collaborative initiatives with other related external societies and several Council Nucleus members are currently contributing to the development of guidelines: 

• from the European Hematology Association on the “Cardiovascular toxicity in older adults with hematologic malignancies”
• from the ‘ERS/ESTS Clinical Practice Guideline Task Force on Fitness for Tumour-specific Treatments of Lung Cancer’